Sign in

You're signed outSign in or to get full access.

Willem Elfrink

Director at HeartBeam
Board

About Willem Elfrink

Willem Elfrink (age 72) is an independent, non‑employee director of HeartBeam, Inc. (NASDAQ: BEAT). He served as Chairman since the company’s founding and stepped down from the chair role in June 2021, remaining on the Board thereafter. Elfrink brings 40+ years of technology commercialization experience; he is Founder and President of WPE Ventures Digitized Solutions and previously served as Cisco’s EVP of Industry Solutions and Chief Globalization Officer. He holds a Bachelor of Engineering from the Institute of Technology in Rotterdam, Netherlands .

Past Roles

OrganizationRoleTenureCommittees/Impact
HeartBeam, Inc.Chairman of the Board; DirectorChairman until June 2021; Director thereafterGovernance leadership from founding; continues board service
Cisco SystemsEVP, Industry Solutions; Chief Globalization Officer2000–2006; 2007–2015Led strategic/global initiatives; launched IoT World Forum
Olivetti; Xerox; HP; DEC; PhilipsSenior management positionsNot disclosedGlobal technology operations experience

External Roles

OrganizationRolePublic/PrivateNotes
WPE Ventures Digitized SolutionsFounder & PresidentPrivateSecurity/digitization solutions investment firm

Board Governance

  • Independence: Board determined seven directors meet Nasdaq independence; Compensation Committee members (including Elfrink) meet independence criteria .
  • Attendance: In 2024 the Board held six meetings; in 2023 it held four meetings. Each director attended at least 75% of Board and applicable committee meetings in both years .
  • Executive sessions: Independent directors hold executive sessions per Nasdaq Rule 5605(b)(2) .
  • Anti‑hedging/pledging policy: Company prohibits hedging, short sales, options trading, margin accounts, or pledging company securities .
  • Related‑party transactions: None above materiality thresholds since the beginning of FY2025 and FY2024 .

Committee Assignments and Roles (current and recent)

Committee202320242025
AuditMember (de Urioste chair; members: de Urioste, Ortigas‑Wedekind, Elfrink) Not a member (de Urioste chair; members: de Urioste, Ortigas‑Wedekind, Ferrari) Not a member (de Urioste chair; members: de Urioste, Ortigas‑Wedekind, Ferrari)
CompensationMember (Ferrari chair; Ferrari, Elfrink, de Urioste) Member (Ferrari chair; Ferrari, Elfrink, Strome, de Urioste) Member (Ferrari chair; Ferrari, Elfrink, Strome, de Urioste)
Nominating & GovernanceMember (Ortigas‑Wedekind chair; Ortigas‑Wedekind, Elfrink) Member (Ortigas‑Wedekind chair; Ortigas‑Wedekind, Elfrink) Member (Ortigas‑Wedekind chair; Ortigas‑Wedekind, Elfrink, Jaff)
CommercializationN/AChair (Elfrink; members: Elfrink, Jaff, Strome, Nelson) Chair (Elfrink; members: Elfrink, Jaff, Strome, Nelson)

Director Election Support (shareholder vote signal)

Metric202320242025
Votes For14,034,713 7,700,810 6,867,987
Votes Against160,535 821,010 162,120
Abstain63,630 46,318 92,499

Fixed Compensation

  • Outside Director Compensation Plan (effective Jan 1, 2022): Board Chair $120,000; Board Member $40,000; Audit Chair $25,000; Audit Member $10,000; Other Committee Chair $15,000; Other Committee Member $10,000 (cash) .
Component (USD)202220232024
Cash Fees (Elfrink)$60,000 $65,639 $75,000
Stock Awards (Elfrink)$75,000 $75,000 $75,000
Total (Elfrink)$135,000 $140,639 $150,000

Interpretation: Cash increased with added committee responsibilities (Comp member; N&G member; Commercialization chair), while equity remained a constant $75k RSU grant—aligns pay with service scope and maintains equity linkage .

Performance Compensation

  • For non‑employee directors, RSUs vest time‑based (generally in full at the next annual meeting); performance metrics are not used for director RSUs .
  • Change‑in‑control: non‑employee director awards fully vest upon a change in control unless otherwise specified (single‑trigger acceleration) .
  • Clawback: all awards subject to clawback under applicable policy and listing standards .
Metric202320242025
Annual Director RSUs Granted to Elfrink (shares)55,147 23,961 33,185
Vesting ScheduleOne‑year, full vest at next annual meeting One‑year, full vest at next annual meeting One‑year, full vest at next annual meeting
Performance ConditionsNone disclosed for directors (time‑based only) None None

Other Directorships & Interlocks

CompanyRoleInterlock/Notes
None disclosed (public company boards)No public company boards disclosed for Elfrink in BEAT proxies .
Compensation Committee compositionMember alongside Ferrari (Exec Chair), de Urioste, Strome (large shareholder)Strome held 9.41% in 2025; participation on Comp Committee may concentrate influence—Board affirms independence criteria for members .

Expertise & Qualifications

  • Technology commercialization and globalization leadership; launched IoT World Forum at Cisco .
  • Multi‑industry senior management experience (Olivetti, Xerox, HP, DEC, Philips) .
  • Founder/investor (WPE Ventures) in security/digitization solutions .
  • Engineering degree (Institute of Technology, Rotterdam) .

Equity Ownership

Metric202320242025
Beneficial Ownership (shares)395,239 460,385 493,433
Ownership % of Outstanding1.52% 1.75% 1.46%
Options Exercisable ≤60 days22,725 32,724 1,914
Vested Options39,897
Unvested Options19,093 (excluded) 10,912 (excluded) 4,103 (excluded)
RSUs Vested (examples)55,147 (2023 vest) 23,961 (2024 vest) 23,961 (2024 vest noted), 33,185 unvested
Unvested RSUs55,147 (excluded) 23,961 (excluded) 33,185 (excluded)
Warrants (BEATW)60,000 exercisable 60,000 exercisable 60,000 exercisable
Other3,640 shares from warrant exercises 3,640 shares from warrant exercises 3,640 shares from warrant exercises

Ownership alignment: Elfrink maintains a meaningful stake with time‑based RSUs and vested/unvested options; no pledging permitted under policy. No related‑party transactions disclosed with his entities .

Insider Trades & Section 16 Compliance

YearNote
2023One late Form 4 filing disclosed for Elfrink (distribution of equity from his venture partnership to non‑affiliated partners) .
2024Company states all Section 16 filings timely except one late Form 4 for de Urioste; no late Elfrink filings indicated .
2025 (covering 2024 year)Company again notes de Urioste had one late Form 4; no late Elfrink filings indicated .

Governance Assessment

  • Strengths:
    • Independence affirmed; consistent >75% meeting attendance; participation in executive sessions .
    • Compensation mix ties director pay to service scope with constant equity component; RSUs vest annually, promoting alignment .
    • Clear anti‑hedging/pledging policy; no related‑party transactions disclosed .
  • Watch items:
    • Change‑in‑control single‑trigger acceleration for director awards (may be viewed as shareholder‑unfriendly) .
    • Large shareholder (Strome, 9.41%) sits on Compensation Committee with Elfrink—potential influence risk despite independence designations .
    • 2023 late Form 4 for Elfrink is a minor compliance blemish; subsequent years show improved timeliness .
  • Shareholder signals:
    • Director election support remained strong across years; 2025 “for” votes ~6.9M vs ~162k “against” .
    • Equity plan increases passed but imply dilution (2024 and 2025 amendments)—continued emphasis on equity compensation at BEAT .

Overall: Elfrink appears engaged and independent with material ownership and leadership across committees, notably chairing Commercialization. Governance policies (anti‑hedging/pledging and clawback) are positives. Monitor compensation oversight dynamics given committee composition, and the single‑trigger acceleration provisions for director equity.